Insulin icodec/semaglutide

Insulin icodec and semaglutide are two significant advancements in the field of diabetes management. Both are injectable medications used to control high blood sugar levels in people with type 2 diabetes.

Insulin Icodec

Insulin icodec is a long-acting basal insulin analogue. It is designed to be administered once weekly, which is a significant improvement over the daily injections required by many other forms of insulin. Insulin icodec works by replacing the insulin that is normally produced by the body and helping move sugar from the blood into other body tissues where it is used for energy. It also prevents the liver from producing more sugar.

Semaglutide

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is used to improve blood sugar control in adults with type 2 diabetes. It is also used for weight management in adults with obesity or overweight. Semaglutide works by mimicking the function of GLP-1, a hormone that increases insulin release, decreases glucagon secretion, and slows gastric emptying.

Comparison

While both insulin icodec and semaglutide are used in the management of type 2 diabetes, they work in different ways and have different dosing schedules. Insulin icodec is a long-acting insulin that needs to be injected once a week, while semaglutide is a GLP-1 receptor agonist that can be taken once a week or once a day, depending on the formulation.

Side Effects

Like all medications, insulin icodec and semaglutide can cause side effects. Common side effects of insulin icodec include reactions at the injection site, weight gain, and low blood sugar. Semaglutide can cause nausea, vomiting, diarrhea, and abdominal pain.

See Also

• Diabetes management
• Insulin
• Type 2 diabetes
• GLP-1 receptor agonist

External Links

‎